A QSAR Study on a Series of Pyrrole Derivatives Acting as Lymphocyte- Specific Kinase (Lck) Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|8|4|649-655

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.8, Iss.4, 2012-07, pp. : 649-655

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

QSAR Study of Benzothiazole Derivatives as p56lck Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 8, 2006-10 ,pp. : 550-560

Bentham Science Publishers

Access to resources Recommend Favorite

A QSAR Study on a Series of Indolin-2-Ones Acting as Non-Receptor Src Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 10, 2011-12 ,pp. : 918-925

Bentham Science Publishers

Access to resources Recommend Favorite

A 3D-QSAR Study on a Series of Benzimidazole Derivatives Acting as Hepatitis C Virus Inhibitors: Application of kNN-Molecular Field Analysis

By  

Medicinal Chemistry, Vol. 6, Iss. 2, 2010-01 ,pp. : 87-90

Bentham Science Publishers

Access to resources Recommend Favorite

A QSAR Study on Some Series of Anticancer Tyrosine Kinase Inhibitors

By  

Medicinal Chemistry, Vol. 9, Iss. 2, 2013-03 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Update on lymphocyte specific kinase inhibitors: a patent survey

By Martin Matthew W   Machacek Michelle R  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1573-1593

Informa Healthcare

Access to resources Recommend Favorite